Expression of cytokine mRNA transcripts in renal cell carcinoma

Immunology and Cell Biology

Volumn 76, Issue 4, 1998, Pages 357-362

  Olive, Colleen ^a,b   Cheung, Catherine ^a   Nicol, David ^a   Falk, Michael C ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokine expression; Immunosuppressive cytokine; Pro inflammatory cytokine; Renal cell carcinoma

Indexed keywords

CYTOKINE; MESSENGER RNA;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIDNEY CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MESSENGER RNA SYNTHESIS; OLIGONUCLEOTIDE PROBE; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; CARCINOMA, RENAL CELL; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; KIDNEY; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031858514     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00759.x     Document Type: Article

References (37)

1. Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma: A clinical, radiologic and pathologic study of 34 cases. Cancer 1976; 38: 2469-80.
2. Topalian SL, Solomon D, Rosenberg SA. Tumour specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 1989; 142: 3714-25.
3. Ioannides CG, Fisk B, Pollack MS, Frazier ML, Taylor-Wharton J, Freedman RS. Cytotoxic T cell clones isolated from ovarian tumour infiltrating lymphocytes recognise common determinants on non-ovarian tumour clones. Scand. J. Immunol. 1993; 37: 413-24.
4. Crannage KE, Rogers K, Jacob G et al. Factors influencing the establishment of tumour-infiltrating lymphocyte cultures from human breast and colon carcinoma. Eur. J. Cancer 1991; 27: 149-54.
5. Hald J, Rasmussen N, Claesson MH. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol. Immunother. 1995; 41: 243-50.
6. Ghosh AK, Moore M. Tumour-infiltrating lymphocytes in cervical carcinoma. Eur. J. Cancer 1992; 28A: 1910-16.
7. Finke JH, Zea AH, Stanley J et al. Loss of T-cell-receptor zeta chain and p56lck in T-cell-infiltrating human renal-cell carcinoma. Cancer Res. 1993; 53: 5613-16.
8. Alexander JP, Kudoh S, Melsop KA et al. T-cells infiltrating renal cell carcinoma display a poor proliferate response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res. 1993; 53: 1380-7.
9. Mitropoulos D, Kooi S, Rodriguez-Villanueva J, Platsoucas CD. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin. Exp. Immunol. 1994; 97: 321-7.
10. Choudhary A, Davodeau F, Moreau A, Peyrat M-A, Bonneville M, Jotereau F. Selective lysis of autologous tumor cells by recurrent γδ tumor-infiltrating lymphocytes from renal carcinoma. J. Immunol. 1995; 154: 3932-40.
11. Schendel DJ, Gansbacher B, Oberneder R et al. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol. 1993; 151: 4209-20.
12. Koo AS, Tso CL, Shimabukuro T, Peyret C, deKernion JB, Belldegrun A. Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J. Immunother. 1991; 10: 347-54.
13. Finke JH, Rayman P, Edinger M et al. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ J cell line. J. Immunother. 1992; 11: 1-11.
14. Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich P-Y. In situ demonstration of renal-cell-carcinoma-specific T-cell clones. Int. J. Cancer 1996; 66: 564-70.
15. Brouwenstijn N, Gaugler B, Kruse KM et al. Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int. J. Cancer 1996; 68: 177-82.
16. Pierce WC, Belldegrun A, Figlin RA. Cellular therapy: Scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma. Semin. Oncol. 1995; 22: 74-80.
17. Tada T, Ohzeki S, Utsumi K et al. Transforming growth factor-β-induced inhibition of T cell function: Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in tumor bearing state. J. Immunol. 1991; 146: 1077-82.
18. Jakobsen MK, Restifo NP, Cohe PA et al. Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line J. Immunother. Emphasis Tumor Immunol. 1995; 17: 222-8.
19. + T cells by B7-transfected melanoma cells. Science 1993; 259: 368-70.
20. Strand S, Hofmann WJ, Hug H et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumour cells: A mechanism of immune evasion? Nature Med. 1996; 2: 1361-6.
21. Hahne M, Rimoldi D, Schroter M et al. Melanoma cell expression of Fas (APO-1/CD95) ligand: Implications for tumor immune escape. Science 1996; 274: 1363-6.
22. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145-73.
23. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997; 18: 263-6.
24. De Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991; 174: 915-24.
25. Kehrl JH. Transforming growth factor-β: An important mediator of immunoregulation. Int. J. Cell Cloning 1991; 9: 438-50.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-9.
27. Olive C, Nicol D, Falk MC. Characterisation of γδ T cells in renal cell carcinoma patients by PCR analysis of T cell receptor transcripts. Cancer Immunol. Immunother. 1997; 44: 27-34.
28. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 1988; 263: 15 335-41.
29. Nakagomi H, Pisa P, Pisa EK et al. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int. J. Cancer 1995; 63: 366-71.
30. Junker U, Knoefel B, Nuske K et al. Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 1996; 8: 794-8.
31. Maeurer MJ, Martin DM, Castelli C et al. Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol. Immunother. 1995; 41: 111-21.
32. Phillips AO, Steadman R, Topley N, Williams JD. Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am. J. Pathol. 1995; 147: 362-74.
33. Wang Q, Redovan C, Tubbs R et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int. J. Cancer 1995; 61: 780-5.
34. Filgueira L, Zuber M, Merlo A et al. Cytokine gene transcription in renal cell carcinoma. Br. J. Surg. 1993; 80: 1322-5.
35. Venetsanakos E, Beckman I, Bradley J, Skinner JM. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. Br. J. Cancer 1997; 75: 1826-30.
36. Thoenes W, Storkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract. 1986; 181: 125-43.
37. Isomaki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritic Rheum. 1996; 39: 386-95.